Blood cancer treatment results examined in major review
NCT ID NCT07282132
First seen Jan 09, 2026 · Last updated Apr 20, 2026 · Updated 20 times
Summary
This study looks back at medical records to see how well ropeginterferon works for people with polycythemia vera, a type of blood cancer. It will follow 150 patients who have already received this treatment to check their blood cell counts, side effects, and how long the treatment keeps working. The goal is to understand the real-world benefits and safety of this medication for managing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTEMIA VERA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.